An improved embryonated chicken egg model for the evaluation of antiviral drugs against influenza A virus

Journal of Virological Methods

Volumn 153, Issue 2, 2008, Pages 218-222

  Wang, Ji Xi ^a   Zhou, Jing Yu ^a   Yang, Qing Wei ^a   Chen, Yang ^a   Li, Xin ^a   Piao, Ying Ai ^b   Li, Hong Yuan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Heilongjiang Provincial Institute for Drug Control   (China)

Author keywords

Antiviral agents; Chick embryo; Influenza A virus; Ribavirin

Indexed keywords

OVALBUMIN; RIBAVIRIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; EGG; HEMAGGLUTINATION TEST; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; NONHUMAN; PRIORITY JOURNAL;

ALLANTOIS; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CHICK EMBRYO; HEMAGGLUTINATION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MICROBIAL SENSITIVITY TESTS; MODELS, ANIMAL; RIBAVIRIN;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 53049083310     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.06.022     Document Type: Article

References (21)

1. Blair E., Darby G., and Goush G. Chemotherapy of Respiratory Virus Infection, Antiviral Therapy (1996), Springer Bios Scientific Publishers Limited, Germany pp. 80-82
2. Burnet F.M. Influenza virus infections of the chick embryo by the amniotic route. Exp. Biol. 18 (1940) 353-360
3. Chen R.S. National Committee of Pharmacopeia. Chinese Pharmacopoeia. second ed. (2005), Chemical Industry Publishing Company, Chinese pp. 260-261
4. Claas E.C., de Jong J.C., van Beek R., Rimmelzwaan G.F., and Osterhaus A.D. Human influenza virus A/HongKong/156/97 (H5N1) infection. Vaccine 16 9-10 (1998) 977-978
5. Claas E.C., Osterhaus A.D., van Beek R., de Jong J.C., Rimmelzwaan G.F., Senne D.A., Krauss S., Shortridge K.F., and Webster R.G. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351 9101 (1998) 472-477
6. Els M.C., Laver W.G., and Air G.M. Sialic acid is cleaved from glycoconjugates at the cell surface when influenza virus neuraminidases were expressed from recombinant vaccinia viruses. Virology 170 1 (1989) 346-351
7. Grassauer A., Egorov A.Y., Ferko B., Romanova I., Katinger H., and Muster T. A host restriction-based selection system for influenza haemagglutinin transfectant viruses. Gen. Virol. 79 (1998) 1405-1409
8. Haertl A., Sauerbrei A., Stelzner A., and Wutzler P. Influenza infection of the embryonated hen's egg-an alternative model for in vivo evaluation of antiviral compounds. Arzneimittelforschung 54 2 (2004) 130-134
9. Kilbourne E.D. Perspectives on pandemics: a research agenda. Infect Dis. 176 Suppl. 1 (1997) S29-S31
10. Lu B., Zhou H., Chan W., Kemble G., and Jin H. Single amino acid substitutions in the hemagglutinin of influenza A/Singapore/21/04 (H3N2) increase virus growth in embryonated chicken eggs. Vaccine 10 24 (44-46) (2006) 6691-6693
11. Lu B., Zhou H., Ye D., and Kemble G. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics. Virology 79 11 (2005) 6763-6771
12. Medeiros R., Escriou N., Naffakh N., Manuguerra J.C., and van der Werf S. Hemagglutinin residues of recent human A (H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology 289 1 (2001) 74-85
13. Mochalova L., Gambaryan A., Romanova J., Tuzikov A., Chinarev A., Katinger D., Katinger H., Egorov A., and Bovin N. Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs. Virology 313 2 (2003) 473-480
14. Noah J.W., Severson W., Noah D.L., Rasmussen L., White E.L., and Jonsson C.B. A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals. Antivir. Res. 73 1 (2007) 50-59
15. Nobusawa E., Ishihara H., Morishita T., Sato K., and Nakajima K. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology 278 2 (2000) 587-596
16. Reed L.J., and Muench H. A simple method of estimating fifty percent endpoints. Hygiene 27 (1938) 495-497
17. Sidwell R.W., and Smee D.F. In vitro and in vivo assay systems for study of influenza virus inhibitors. Antivir. Res. 48 (2000) 1-16
18. Thompson W.W., Shay D.K., Weintraub E., Brammer L., and Bridges C.B. Influenza-associated hospitalizations in the United States. J. JAMA 292 11 (2004) 1333-1340
19. Taubenberger J.K., Reid A.H., Lourens R.M., Wang R., and Jin G. Characterization of the 1918 influenza virus polymerase genes. Nature 437 (2005) 889-893
20. Xu X., Smith C.B., Mungall B.A., Lindstrom S.E., and Hall H.E. Intercontinental circulation of human influenza A (H1N2) reassortant viruses during the 2001-2002 influenza season. Infect Dis. 186 (2002) 1490-1493
21. World Health Organization (WHO), Department of Communicable Disease Suveillance and Respancse, 2002. Hemagglutination and Hemagglutination inhibition test, WHO Manual on Animal Influenza Diagnosis and Surveillance. WHO/CDS/CSR/NCS/2002.5, 25, pp. 25-32.